Registry Progress

Total number of patients
Prospective patient-level data
9,805
4,752
Target for prospective severe asthma patients recruitment by 2022

We are delighted to have recently welcomed our host-country, Singapore to the ISAR family!

The expertise we have gained from our local collaborators, from both primary and specialist care will help us to improve outcomes for patients with severe and potentially severe asthma now and well into the future.

May our newest collaboration be far-reaching and successful for all those involved!

Latest ISAR Collaborators:

    • Singapore
    • Mexico
    • Argentina
    • Colombia
    • UAE (Dubai)
    • Saudi Arabia
    • Taiwan
    • Kuwait
Agreement executed
Newly engaged
Agreements in Progress

ISAR collaborators Placeholder
ISAR collaborators

The International Severe Asthma Registry is a global collaborative initiative to gather anonymous, longitudinal, real-life data for patients with severe asthma from over 22 countries. ISAR offers a rich source of real-life data for scientific research to understand and improve symptoms, treatments and patient outcomes for severe asthma. The database will also provide an international platform for research collaboration in respiratory medicine and patient care.